Can a 6.2 cm uterine fibroid still be treated with minimally invasive surgery?
Oct 26, 2021
Source: Cainiu Health
Dr. Chen Yunmei
Introduction
In general, a uterine fibroid measuring 6.2 cm can be treated effectively with minimally invasive surgery. Since a fibroid of approximately 6 cm is not considered large, the patient should actively cooperate with the physician by completing the required preoperative evaluations to fully understand both the condition and their overall health status. Subsequently, a standardized and effective surgical plan can be implemented, yielding excellent treatment outcomes. Two commonly used minimally invasive surgical approaches are available.
Uterine fibroids are a progressive condition. Generally, if a fibroid exceeds 5 cm in diameter, surgical intervention may be required promptly. In such cases, conventional therapies—including drug treatment—often yield limited efficacy, necessitating timely management. With advances in medical technology, minimally invasive approaches have become viable options for treating fibroids, avoiding open abdominal surgery and reducing the risk of complications. So, can a 6.2-cm uterine fibroid still be treated with minimally invasive surgery? Below, we address this question.
Can a 6.2-cm uterine fibroid be treated with minimally invasive surgery?
In general, a 6.2-cm uterine fibroid is still amenable to minimally invasive surgical treatment. A tumor measuring approximately 6 cm is not considered excessively large. However, successful outcomes depend on the patient’s active cooperation with the physician—including thorough preoperative evaluations—to fully assess both the fibroid characteristics and the patient’s overall health status. Once an appropriate, evidence-based surgical plan is selected, excellent therapeutic results can be achieved. Two common minimally invasive procedures include hysteroscopic and laparoscopic surgery. Patients should actively cooperate with their physicians throughout the surgical process. During treatment, maintaining healthy lifestyle and dietary habits is essential: avoid overeating or binge eating, and abstain from sexual activity throughout the treatment period. Additionally, patients undergoing uterine fibroid surgery should schedule regular follow-up examinations based on their individual postoperative recovery progress.
Knowledge Expansion: Symptoms of Uterine Fibroids
1. Abnormal Uterine Bleeding
This manifests as menorrhagia (increased menstrual flow), prolonged menses, shortened menstrual cycles, or irregular vaginal bleeding. Abnormal uterine bleeding is most commonly associated with submucosal and intramural fibroids. Acute abdominal pain may occur when subserosal fibroids undergo peduncle torsion or red degeneration. Coexisting endometriosis or adenomyosis is relatively common and may cause dysmenorrhea. Furthermore, chronic menorrhagia or irregular vaginal bleeding may lead to iron-deficiency anemia; severe anemia occurs more frequently in patients with submucosal fibroids.
2. Palpable Abdominal Mass
Associated pressure symptoms may also occur. When the uterus enlarges to the size equivalent to a 3-month pregnancy—or when a large subserosal fibroid is located at the fundus—a palpable abdominal mass is often detectable, especially noticeable upon waking with a full bladder. Such enlargement may compress adjacent organs: anterior wall fibroids near the bladder may cause urinary frequency and urgency; large cervical fibroids compressing the bladder may result in urinary obstruction or even urinary retention; posterior wall fibroids—particularly those located in the isthmus or posterior lip of the cervix—may compress the rectum.
The above outlines whether a 6.2-cm uterine fibroid remains eligible for minimally invasive treatment. We hope this information proves helpful to you.
